supp.fit

Berberine and Coenzyme Q10: study protocols

6 study groups took Berberine together with Coenzyme Q10. These are the doses the studies gave. They are not a recommendation.

Berberine: what the research found →

Dose per serving from research: Berberine

6 study groups in 5 studies say how much Berberine participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 100% of 6 study groups.

Daily doseStudy groups
250 mg to 500 mg
6

Dose per serving from research: Coenzyme Q10

6 study groups in 5 studies say how much Coenzyme Q10 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 mg to 2.5 mg, 100% of 6 study groups.

Daily doseStudy groups
1 mg to 2.5 mg
6

Commonly used together

6 of 6 study groups took Berberine and Coenzyme Q10 with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Folic Acid
5
Policosanol
5
Red Yeast Rice
5
Astaxanthin
4

6 study groups

Study
Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial
2015 · Combination A · Adults aged 18–70 with hypercholesterolemia not requiring statins or statin-intolerant
500 mg2 mg4 weeks23
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q(10) on lipid levels: a randomized, double-blind, placebo controlled study
2017 · Body Lipid (BL) · Adults aged 18–75, both sexes, with mild-to-moderate hypercholesterolemia
500 mg2 mg4 weeks—
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q(10) on lipid levels: a randomized, double-blind, placebo controlled study
2017 · Armolipid Plus (AM) · Adults aged 18–75, both sexes, with mild-to-moderate hypercholesterolemia
500 mg2 mg4 weeks—
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial
2019 · Armolipid Plus (AP) · Adults aged 18–70 with metabolic syndrome and left ventricular hypertrophy; men and women
500 mg2 mg24 weeks71
Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial
2014 · Intervention (Armolipid Plus/AP) · Men and women older than 18 years with mild-moderate hypercholesterolemia and elevated LDL-c, candidates for lifestyle intervention without hypolipemic drug treatment
500 mg2 mg12 weeks51
Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial
2019 · Nutraceutical B · Adults aged 18–75 with elevated serum cholesterol not requiring statins or statin-intolerant; people with cardiovascular disease and uncontrolled diabetes were excluded.
500 mg2 mg6 weeks23
Berberine and Coenzyme Q10: study protocols | supp.fit